SG11201610921PA - A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof - Google Patents

A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

Info

Publication number
SG11201610921PA
SG11201610921PA SG11201610921PA SG11201610921PA SG11201610921PA SG 11201610921P A SG11201610921P A SG 11201610921PA SG 11201610921P A SG11201610921P A SG 11201610921PA SG 11201610921P A SG11201610921P A SG 11201610921PA SG 11201610921P A SG11201610921P A SG 11201610921PA
Authority
SG
Singapore
Prior art keywords
prepare
freeze dried
vaccine formulation
rotavirus vaccine
dried rotavirus
Prior art date
Application number
SG11201610921PA
Other languages
English (en)
Inventor
Davinder Gill
Madhu Madan
Dr Sachin Kale
Tarun Sharma
Nidhi Shukla
Deepa Sikriwal
Robert Evans
Original Assignee
Msd Wellcome Trust Hilleman Lab Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msd Wellcome Trust Hilleman Lab Pvt Ltd filed Critical Msd Wellcome Trust Hilleman Lab Pvt Ltd
Publication of SG11201610921PA publication Critical patent/SG11201610921PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
SG11201610921PA 2014-07-18 2015-07-16 A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof SG11201610921PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2037DE2014 2014-07-18
PCT/IB2015/055383 WO2016009381A2 (en) 2014-07-18 2015-07-16 A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

Publications (1)

Publication Number Publication Date
SG11201610921PA true SG11201610921PA (en) 2017-02-27

Family

ID=55079131

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201610921PA SG11201610921PA (en) 2014-07-18 2015-07-16 A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

Country Status (9)

Country Link
US (1) US10532093B2 (ja)
EP (1) EP3169313B1 (ja)
JP (1) JP6674945B2 (ja)
KR (1) KR20170028992A (ja)
CN (1) CN106794145A (ja)
AU (1) AU2015291181A1 (ja)
BR (1) BR112017000515A2 (ja)
SG (1) SG11201610921PA (ja)
WO (1) WO2016009381A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130309273A1 (en) 2012-05-17 2013-11-21 Kimberly Hassett Thermostable Vaccine Compositions and Methods of Preparing Same
US11273127B2 (en) 2014-05-06 2022-03-15 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for thermally stable multi-targeted antigens
US10751408B2 (en) 2016-02-23 2020-08-25 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
KR20190111117A (ko) * 2017-02-14 2019-10-01 인벤트프라이즈 엘엘씨 열 안정성 액체 로타바이러스 백신
US11110163B2 (en) 2017-02-14 2021-09-07 Inventprise, Llc Heat stable vaccines
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes
CN111948153A (zh) * 2020-07-16 2020-11-17 深圳市锦瑞生物科技有限公司 一种冻干试剂球、生化分析芯片及血清总钙测定方法
CN112675134A (zh) * 2020-12-29 2021-04-20 深圳康泰生物制品股份有限公司 重组乙型肝炎抗原冻干保护剂、重组乙型肝炎抗原冻干疫苗及其制备方法
CN115197918B (zh) * 2022-07-22 2023-07-18 中国生物技术股份有限公司 一种病毒保护剂及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
DK0939648T3 (da) * 1996-09-26 2008-02-11 Merck & Co Inc Rotavirusvaccineformuleringer
US6403098B1 (en) * 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
US6616931B1 (en) * 1996-09-26 2003-09-09 Merck & Co., Inc. Rotavirus vaccine formulations
WO2007132480A2 (en) * 2006-05-12 2007-11-22 Bharat Biotech International Limited A composition useful as a vaccine
KR101411933B1 (ko) * 2006-11-02 2014-06-27 옴릭스 바이오파머슈티컬스 리미티드 마이크로화 방법
BRPI0915696B8 (pt) * 2008-11-07 2021-05-25 Serum Institute Of India Ltd composição de vacina de rotavírus liofilizada e método de preparar a referida composição
PL2364141T5 (pl) * 2008-12-08 2018-02-28 Ratiopharm Gmbh Kompaktorowana moksyfloksacyna
BR112012000588A2 (pt) * 2009-07-13 2020-08-11 Bharat Biotech International Limited composição, composição líquida, composição liofilizada e método para produzir um rotavirus atenuado
US20110243988A1 (en) * 2009-10-01 2011-10-06 Aridis Pharmaceuticals Methods and Compositions for Stabilization of a Virus Vaccine
CN101947321B (zh) * 2010-09-30 2012-01-11 郑州后羿制药有限公司 活疫苗用耐热冻干保护剂及其制备方法及鸡新城疫活疫苗
KR20150000389A (ko) * 2011-04-28 2015-01-02 인터내셔널 메디카 파운데이션 액상 백신 제제

Also Published As

Publication number Publication date
WO2016009381A3 (en) 2016-03-17
BR112017000515A2 (pt) 2017-11-14
US10532093B2 (en) 2020-01-14
EP3169313B1 (en) 2019-08-28
JP2017522327A (ja) 2017-08-10
JP6674945B2 (ja) 2020-04-01
EP3169313A2 (en) 2017-05-24
CN106794145A (zh) 2017-05-31
AU2015291181A1 (en) 2017-02-02
US20170165354A1 (en) 2017-06-15
WO2016009381A2 (en) 2016-01-21
EP3169313A4 (en) 2018-02-07
KR20170028992A (ko) 2017-03-14

Similar Documents

Publication Publication Date Title
SG11201610921PA (en) A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof
ZA201605308B (en) Plant growth promoting rhizobacterial strains and their uses
GB2542057B (en) Devices and methods related to directional couplers
GB201410971D0 (en) Vaccine
GB201400787D0 (en) Heteroaryl alkyne derivatives and uses thereof
HRP20181507T1 (hr) Modificirana sulfamidaza i njena proizvodnja
DK3212166T3 (da) Varme-steriliseret formulering omfattende chitosan og fremgangsmåde til fremstilling deraf
IL251665A0 (en) Dry powder formulation
ZA201702490B (en) Process for preparing a fat slurry and for preparing a spread with said slurry
HK1248536A1 (zh) 疫苗組合物及其用途
SG11201610920WA (en) An improved thermostable spray dried rotavirus vaccine formulation and process thereof
GB201621546D0 (en) Bootstrapping a device to a wireless network
PL3034975T3 (pl) Sposób i urządzenie suszarnicze do suszenia materiału suszonego
EP3206504B8 (en) Process for preparing a fat slurry and for preparing a spread with said slurry
GB201417214D0 (en) Vaccine
LU92569B1 (en) Novel water soluble 6-thioalkyl-cyclodextrins and uses thereof
SG10202111096SA (en) Process for preparing a crassocephalum crepidioides extract, extract prepared thereby and use of the extract
AU2014902031A0 (en) Immunogenic vaccines and uses thereof
GB201410060D0 (en) Multivalent and monovalent vaccines
GB201405034D0 (en) The high and dry vacuum head
GB201419853D0 (en) A utility stick
GB201419201D0 (en) Dry dam
GB201405857D0 (en) Immunogenic formulations
GB201412110D0 (en) One-step thermoboard and one-step termoboard dry
GB201411371D0 (en) Immunogenic composition